David A Schwartz Selected Research

Blood Component Removal (Apheresis)

2/2008	Nasal Crohn's disease /apheresis.
7/2006	Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Schwartz Research Topics

Disease

33	Inflammation (Inflammations) 01/2023 - 01/2002
29	Crohn Disease (Crohn's Disease) 02/2024 - 01/2005
25	Asthma (Bronchial Asthma) 01/2022 - 04/2002
23	Idiopathic Pulmonary Fibrosis 01/2024 - 05/2002
19	Fibrosis (Cirrhosis) 11/2023 - 12/2002
19	Ulcerative Colitis 01/2022 - 07/2006
14	Infections 01/2024 - 08/2007
13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 01/2013
12	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024 - 07/2002
11	Lung Injury 01/2023 - 12/2003
10	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 05/2002
9	Fistula 02/2024 - 08/2005
8	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 02/2005
8	Lung Diseases (Lung Disease) 01/2023 - 12/2002
8	Sepsis (Septicemia) 12/2018 - 12/2003
7	Colitis 10/2023 - 01/2010
7	Neoplasms (Cancer) 01/2023 - 12/2002
6	Necrosis 01/2023 - 09/2002
6	Disease Progression 01/2016 - 01/2004
6	Respiratory Hypersensitivity 01/2016 - 07/2004
6	Airway Remodeling 07/2008 - 04/2002
5	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 10/2007
4	COVID-19 03/2024 - 07/2021
4	Hypoxia (Hypoxemia) 01/2022 - 03/2014
3	Cysts 01/2023 - 10/2016
3	Pouchitis 01/2022 - 10/2007
3	Atherosclerosis 12/2019 - 07/2002
3	Abscess 01/2019 - 08/2005
3	Eosinophilia 01/2018 - 07/2003
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015 - 02/2005
3	Pneumonia (Pneumonitis) 01/2010 - 01/2004
2	Pathologic Constriction (Stenosis) 01/2023 - 01/2019
2	Stillbirth 01/2023 - 01/2023
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 11/2020
2	Rheumatoid Arthritis 01/2021 - 03/2008
2	Hyperplasia 12/2019 - 12/2003
2	Otitis Media 01/2019 - 11/2018
2	Cystic Fibrosis (Mucoviscidosis) 12/2018 - 12/2006
2	Seasonal Allergic Rhinitis (Hay Fever) 04/2015 - 05/2008
2	Wounds and Injuries (Trauma) 12/2013 - 09/2010

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2002
13	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2006
11	CytokinesIBA 05/2019 - 09/2002
10	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 01/2007
10	EndotoxinsIBA 01/2013 - 04/2002
9	LipopolysaccharidesIBA 03/2014 - 04/2002
8	Surface-Active Agents (Surfactants)IBA 12/2018 - 05/2002
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 11/2006
7	RNA (Ribonucleic Acid)IBA 11/2023 - 07/2015
7	AllergensIBA 09/2014 - 04/2002
7	Toll-Like Receptor 4IBA 01/2010 - 05/2002
6	AntigensIBA 01/2022 - 04/2002
6	MucinsIBA 01/2022 - 04/2011
6	OzoneIBA 01/2016 - 04/2002
6	SmokeIBA 01/2015 - 04/2008
5	FibrinIBA 01/2023 - 09/2012
5	Immunoglobulin E (IgE)IBA 07/2015 - 01/2002
4	VaccinesIBA 03/2024 - 12/2018
4	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 11/2023 - 01/2023
4	Mucin-5BIBA 01/2023 - 01/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2003
4	Certolizumab Pegol FDA Link 01/2018 - 03/2008
4	Messenger RNA (mRNA)IBA 10/2016 - 11/2008
4	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 11/2008
4	Methacholine Chloride (Methacholine)FDA Link 02/2015 - 11/2002
3	CollagenIBA 01/2023 - 01/2007
3	indium-bleomycinIBA 01/2021 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2015
3	Protein CIBA 12/2018 - 05/2002
3	Adalimumab (Humira)FDA Link 01/2018 - 11/2006
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 09/2005
3	Arginine (L-Arginine)FDA Link 01/2016 - 01/2010
3	Infliximab (Remicade)FDA Link 02/2014 - 08/2005
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2024 - 07/2023
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 07/2023
2	MicroRNAs (MicroRNA)IBA 11/2023 - 10/2016
2	Phenobarbital (Luminal)FDA Link 01/2023 - 12/2002
2	vedolizumabIBA 01/2022 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2006
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 01/2016
2	P-2 (P 2)IBA 12/2018 - 04/2011
2	Amino Acids FDA Link 01/2018 - 01/2016
2	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 01/2016
2	Mesalamine (Mesalazine)FDA LinkGeneric 10/2017 - 01/2005
2	EnzymesIBA 01/2016 - 11/2006
2	Prednisone (Sone)FDA LinkGeneric 12/2015 - 08/2005
2	Azathioprine (Imuran)FDA LinkGeneric 12/2015 - 09/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2015 - 09/2007
2	Interleukin-13IBA 07/2015 - 07/2003
2	Interleukin-4 (Interleukin 4)IBA 07/2015 - 07/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014 - 01/2004

Therapy/Procedure

36	Therapeutics 01/2023 - 07/2002
5	Restorative Proctocolectomy 01/2022 - 10/2007
3	Precision Medicine 04/2024 - 12/2018
3	Lung Transplantation 01/2019 - 09/2003
2	Biological Therapy 12/2023 - 01/2019
2	Injections 12/2023 - 01/2018
2	Colonic Pouches (S Pouch) 01/2022 - 04/2009
2	Operative Surgical Procedures 10/2021 - 09/2009
2	Aftercare (After-Treatment) 02/2015 - 11/2006